Please login to the form below

companion diagnostics

This page shows the latest companion diagnostics news and features for those working in and with pharma, biotech and healthcare.

Edging Evolution

Value created beyond the pill, such as companion diagnostics and devices, are good examples of environmental selection, while me-too products that are not granted market access illustrate the market disfavouring

Latest news

Lynparza could soon add first line ovarian use in Europe

As with other ‘personalised medicine’ drugs, the company’s commercial division is aiming to maximise uptake by broadening access to companion diagnostics which can identify BRCA mutations in patients across these
Gradually, then suddenly

The second kept on looking for whole-disease area blockbusters long after companion diagnostics had fractured its market.
Roche agrees $2.4bn takeover of genomics player Foundation

Prior to the approval of F1CDx, most companion diagnostics for cancer matched one test to one drug, but the FDA said that using Foundation’s test could identify which patients with ... There has also been movement at the federal level in the US, with
Morning brief: Sanofi's shaky start, pharma begins talks with UK government and more

Foundation Medicine is a major player in the emerging field of next generation cancer diagnostics and genomic profiling, and two developments yesterday confirmed it as a leader in what will undoubtedly ... If approved, this test could be the
EMA starts firming up its stance on personalised medicines

The European Medicines Agency (EMA) hopes that when finalised they will help optimise the co-development of medicines and companion diagnostics. ... As diagnostic medical devices, companion diagnostics do not fall within the oversight of the EMA, but the

More from news
Approximately 3 fully matching, plus 30 partially matching documents found.

Latest Intelligence

Leading AstraZeneca’s return to growth in Europe

Diagnostics and cracking the market access code. For many of the company’s new generation of treatments, the uptake of companion diagnostics into routine clinical practice is another part of the ... Reic said the adoption of diagnostics into standard
Encouraging signs in biomarker R&D

The response has been a surge of interest in developing novel companion biomarkers, and biomarkers that allow personalisation of therapy. ... FDA is stimulating this approach and one can see the development of, for instance, TMB assays, targeted gene
25 Women Leaders in UK Healthcare

9. RUTH MARCH. Precision medicine leader. Precision medicine and the use of companion diagnostics now plays a fully integrated role in many successful new cancer therapies. ... But how do you deliver these companion diagnostics to healthcare systems and
AstraZeneca’s oncology renaissance

This encompasses approaches to detecting cancers earlier, including novel techniques such as liquid biopsies (aka circulating tumour DNA tests) and new companion diagnostics.
Breakthrough innovation

The same key agile principles with a different twist. Many pharmaceutical companies are increasingly looking to innovate through the development of companion diagnostics and drug delivery devices, and/or services such ... An optimal innovation approach.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

Dr Holger Adelmann joins DIA EMEA

In that role he oversaw the reengineering of its clinical biomarker and companion diagnostics business to align with upcoming portfolio demands.
FlowMetric Diagnostics names president

FlowMetric Diagnostics, a provider of flow cytometry and cell sorting services, has appointed Amy Williams as its president. ... It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised
Roche appoints new oncology research head

Commenting on Pao's appointment, Reed said: "William is recognised as one of the world's leading molecular oncologists, with world class expertise in targeted cancer therapeutics, translational medicine, molecular diagnostics, ... diagnostics company,

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Mastering the precision medicine opportunity

Novartis and Roche are two champions of personalised medicine, shaping the area with the launch of targeted treatments combined with a companion diagnostic to support patient identification. ... approval of their new FoundationOne CDx, the first and
Excellence in oncology: Developing an effective biomarker strategy

Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.
Research Partnership

Medical devices and diagnostics. Our experience covers everything from insulin pens to large-scale surgical systems. ... Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company

Madmicrobe Studios

MadMicrobe is an award-winning team of animators and science experts creating photo real life-science animation content for the healthcare and...

Latest intelligence

Surviving cancer: a new era for patients: Now more than ever, a shift in perspective is needed...
Crisis? No problem!: Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?: First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....